---
title: JYMed Peptide vs PolyPeptide Group
slug_a: jymedtech
slug_b: polypeptide
site: cdmo
review_signal_gate: closed
canonical_path: /compare/jymedtech/polypeptide
generated_by: BioBM Editorial AI
---

# JYMed Peptide vs PolyPeptide Group

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

JYMed Peptide (jymedtech) is listed for cdmo. Peptide CDMO offering custom synthesis from milligrams to metric tons, with 13 cGMP lines and FDA-, NMPA- and EDQM-approved sites. Provides peptide API manufacturing plus syringe, cartridge and lyophilized finished-dose filling at its Shenzhen site.

Services: 12. Modalities: 1. Indications: 0. Locations: 4. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (12).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

PolyPeptide Group (polypeptide) is listed for cdmo. Specialized global CDMO for peptide-based active pharmaceutical ingredients, supporting development and manufacturing of proprietary and generic APIs with expertise in peptide synthesis and GMP manufacturing.

Services: 7. Modalities: 1. Indications: 1. Locations: 1. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (7).

Review summary: Review summary withheld until site-level review gate opens.